Hospice Insights Podcast - High Risk Hospices Are in the Hot Seat Across Six States
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 273: Navigating FDA Regulation for Life Sciences Companies with Christin Carey of Maynard Nexsen
Hot Flashes, Cold Policies: Legal and Benefit Strategies for Menopause — Hiring to Firing Podcast
PODCAST – 2026 To Do: HIPAA Compliance
2026 To Do: HIPAA Compliance
Health-E Law Podcast, Episode 24 | ViVE 2026: AI and the Future of Healthcare
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 272: Humanism and Transplant Care with Dr. Joseph Scalea of MUSC
AI in Healthcare: Five Healthcare AI Stories You Need to Know This Week - April 3, 2026
How to Stay HIPAA Compliant When Using Health Care Analytics
PBM Reform 2026: What Recent Legislation Means for the Industry
McDonald Hopkins Legal Diagnosis Podcast, Episode 8: Stark Law
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 271: Advancing Neurotrauma Treatments with Ken Webb of NeuroHope Therapeutics
AI in Healthcare: Five Healthcare AI Stories You Need to Know This Week – March 27, 2026
Health-e Law Podcast, Episode 23 | The Future of Brain Tech With Dr. Newton Howard
Hospice Insights Podcast - What’s New? CMS Provisional Period of Enhanced Oversight Application to “New” Hospices
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 270: Building a Future-Ready Workforce in Life Sciences with Daniel Grove of Lonza
State AGs in Action: Health Care Enforcement in 2026 – Speaking of Litigation Video Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 269: Investing in Distributed Healthcare with Gordon Maner of Frontline Healthcare Partners
Podcast - States Propose New Laws Affecting Healthcare Real Estate Investors and Owners
Hospice Insights Podcast - PPEO Playbook: The High-Stakes Game Hospices Can’t Afford to Lose
Key Takeaways - The FY 2027 budget process is underway, with the president submitting his proposal April 3 and committees beginning hearings the week of April 13. Senate leadership is expected to move a budget resolution the...more
In the wake of Loper Bright, many employers have questioned whether long-standing federal regulations remain on solid footing. On April 1, 2026, in DOL v. Americare Healthcare Services, the U.S. Court of Appeals for the Sixth...more
The Food and Drug Administration (FDA) has signaled a reassessment of its dietary supplement regulatory framework, recently framing a public meeting around key questions on ingredient scope, identity, manufacturing changes,...more
A recent defense victory reinforces key procedural protections for defendants and pushes back against a growing plaintiff‑side litigation tactic....more
In anticipation of the CY2027 bid deadline, CMS released both the CY2027 final rule for Medicare Advantage (“MA”) and Medicare Part D (the “Final Rule”) as well as the CY2027 MA Capitation Rates and Part C and Part D Payment...more
On January 13, 2025, Conduent Business Services LLC (Conduent) discovered it was the subject of a cybersecurity incident involving unauthorized access to its systems between October 21, 2024, and January 13, 2025....more
This case was filed in 2018 when Alvogen submitted to the FDA an ANDA for approval to market generic Belbuca, a buprenorphine buccal film used to administer the drug transmucosally....more
Since September 2024, CMS’s Medicare Administrative Contractors have been conducting expanded prepayment reviews (also known as “EPRs” or targeted high-risk reviews) of existing hospice providers in Arizona, California,...more
On April 10, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the fiscal year (FY) 2027 Inpatient Prospective Payment System (IPPS) proposed rule....more
Time’s up! Covered entities (CEs) and substance use disorder (SUD) providers who accept federal assistance have had two years to comply with a rule updating privacy policies, as well as implement breach notification...more
Welcome to our fourth issue of 2026 of The Health Record -- our healthcare law insights e-newsletter. In this edition, we look at the record setting False Claims Act recovery results from 2025, proposed cuts at HHS,...more
Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary...more
In an Election Year, Affordability Takes Center Stage - As the midterm elections draw near, “kitchen table” issues, like affordability, will dominate the congressional investigations landscape for both parties. The...more
On April 2, 2026, Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration has approved an extension to the dosing intervals for EYLEA HD (aflibercept) patients with wet age-related macular degeneration...more
New 10-Year ACO Demo (2027–2036): Starting January 1, 2027, providers will have the opportunity to participate in a decade-long, voluntary ACO program with no benchmark rebasing throughout the 10-year span. The Long-term...more
Join legal and industry professionals on April 29, 2026, at 12:00 pm PT, for the California Senior Living–2026 Legal, Regulatory, and Insurance Update, a timely webinar designed to help administrators, owners, and operators...more
The U.S. Food and Drug Administration’s (FDA) Human Food Program (HFP) has prepared a list of priority research, data, and method needs that, if fulfilled, will help FDA better understand the underlying factors that may cause...more
Key Points: • Senate Bill 220, the bipartisan "Putting Georgia's Patients First Act," would eliminate Georgia's 5% THC cap in favor of a 12,000-milligram possession limit and otherwise transform what has been the nation's...more
Welcome to our Life sciences and healthcare insights report, where our global team share their insights on the most important commercial, legal, and regulatory issues facing life sciences and healthcare companies around the...more
The Food and Drug Administration (FDA) is urging innovators, providers, and patients to “reimagine the home as an integral part of the health care system.”...more
The United States Department of Health and Human Services (HHS) provides a helpful set of questions and answers on its website regarding the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Health care...more
On Feb. 3, 2025, H.R.7148 the Consolidated Appropriations Act, 2026[1] ( CAA) became law. Included in the Act, there were many new provisions surrounding the pharmacy industry emphasizing pharmacy contracting, pharmacy...more
Last month, the US District Court for the District of Columbia struck down a 2013 policy issued by the US Department of Health and Human Services Health Resources and Services Administration (HRSA) regarding the Section 340B...more
On April 1, 2026,the U.S. Food & Drug Administration (FDA) issued a statement clarifying its compliance policy on the conditions that must be met for compounded drugs to qualify for the exemptions under Sections 503A and...more
Key Takeaways - HRSA has extended the deadline for comments on its proposed 340B rebate model pilot program to April 20, 2026. Covered entities have a limited window to submit detailed feedback on how the model would affect...more